FPPs were used to more efficiently deliver Centyrins into cells. Helps to explain the comment by Dr Hayes in the 18 April 2017 announcement when he noted the progress made by the drug discovery team in advancing the more efficient intracellular delivery of biologics.
Scaffolds are one of Phylogica's secondary priorities. Secondary in terms of priority not importance.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
0.020(1.61%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.29 | $1.25 | $79.24K | 62.81K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 23727 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 444 | 1 |
View Market Depth
| Last trade - 14.18pm 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |